Modulight (MODU) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
31 Oct, 2025Executive summary
Revenue grew 176% year-over-year in Q3 and over 100% for the first nine months, with four consecutive quarters of growth and improved profitability driven by a diversified customer base and product mix.
EBITDA losses narrowed significantly, with Q3 at -€184k versus -€1,278k last year, reflecting operational efficiency and reduced one-time costs.
Free cash flow from operations improved but remained negative at -€1,076k in Q3 and -€3,942k for the nine months.
The transition to the pay-per-treatment (PPT) business model is progressing, with increasing adoption and positive customer feedback.
Customer base continues to diversify, with 60% listed companies and 35% having over €1bn in revenue.
Financial highlights
Q3 2025 revenue was €1,765k, up 176% year-over-year; 1-9/2025 revenue was €5,333k, up 100%.
Q3 EBITDA was -€184k (improved from -€1,278k); 1-9/2025 EBITDA was -€810k (improved from -€3,813k).
Q3 EBIT was -€1,220k (improved from -€2,108k); 1-9/2025 EBIT was -€3,861k (improved from -€6,134k).
Q3 EPS was -€0.03; 1-9/2025 EPS was -€0.09.
Cash and cash equivalents at period end: €10,550k; net debt: -€7,309k; gearing ratio: -16.1%; equity ratio: 89.7%.
Outlook and guidance
Most projects are in early development, focused on commercializing proprietary products and transitioning to a treatment-session-based payment model.
Macroeconomic and geopolitical uncertainties make revenue forecasting difficult; no formal guidance provided for 2025.
Latest events from Modulight
- Record revenue growth and improved profitability, driven by PPT model and project expansion.MODU
Q4 202520 Feb 2026 - Q2 2024 revenue fell 13% YoY, but EBITDA loss narrowed and cash flow improved as the pipeline grew.MODU
Q2 202423 Jan 2026 - Q3 revenue up 58% YoY, EBITDA loss narrows, and PPT model and R&D pipeline expand.MODU
Q3 202419 Jan 2026 - Revenue up 52% and EBITDA up 56%, driven by US growth and pay-per-treatment expansion.MODU
Q1 202524 Dec 2025 - Q4 revenue up 40% YoY, cash flow and margins improved as PPT model reached 50 hospitals.MODU
Q4 202424 Dec 2025 - Q2 revenue doubled and EBITDA neared zero as the pipeline and global customer base expanded.MODU
Q2 202523 Nov 2025